http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-51486-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ae46e97df67a495d051dc2fde8b00b2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate | 1991-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6471fb1c342f6f17e46abaafd9aed2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb36d877966bd22ff4a931e265aed3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68406535199f883f7365a4afc21813df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0af0994aa60f1820b7c27d51c18cd27f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2866befc48d3af62905b59bfc91c38c8 |
| publicationDate | 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-51486-A1 |
| titleOfInvention | Preparation for treatment of chronic respiratory insufficiency |
| abstract | The agent is applied with patients suffering from chronical lung diseases - chronical obstructive lung disease, chronical bronchitis, lung emphysemas, pneumosclerosis, bronchiectasia, chronic bronchial asthma. It substantially enhances the partial oxygen pressure in the arterial blood, reduces the partial pressure of the carbon dioxide and increases the hemoglobin saturation. The agent is a zinc complex with bioactive ligands - aminoacids, in particular asparagin or orotic, and is orally applied in 40 to 120 mg a day, calculated as zinc. |
| priorityDate | 1991-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.